Medical News

RSS

Waters first quarter sales rise 16% to $428 million

Waters Corporation reported first quarter 2011 sales of $428 million, an increase of 16%, from sales of $368 million in the first quarter of 2010. In the quarter, foreign currency translation added 2% to sales growth.

26 Apr 2011

BioControl Medical initiates INOVATE-HF study of CardioFit system

BioControl Medical, a medical technology company that develops and markets advanced implantable devices for the treatment of autonomic disorders, has announced first patient enrollment in the INOVATE-HF (INcrease Of VAgal TonE in Heart Failure) clinical study at Northwest Texas Heart Hospital, Amarillo, Texas, by study investigator Suresh Neelagaru, M.D.

26 Apr 2011

Amedisys net service revenue decreases 11.8% to $364.3 million

Amedisys, Inc., a leading home health and hospice company, today reported its financial results for the first quarter ended March 31, 2011 and reaffirms 2011 guidance.

26 Apr 2011

Accuray announces expiration of HSR waiting period for TomoTherapy acquisition

Accuray Incorporated, a global leader in the field of radiosurgery, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, in connection with the previously announced acquisition of TomoTherapy Incorporated.

26 Apr 2011

PolyMedix defensin-mimetic antibiotic compounds show antimicrobial efficacy against anthrax

PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat patients with acute infectious diseases and cardiovascular disorders, announced today that several of its defensin-mimetic antibiotic compounds have shown antimicrobial efficacy in an animal model against the bacteria that causes anthrax.

26 Apr 2011

First Edition: April 26, 2011

Today's headlines include reports about the political ads and positions being inspired by the Ryan budget plan.

26 Apr 2011

LCA-Vision reports first profitable quarter in three years

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operational results for the three months ended March 31, 2011.

26 Apr 2011

New nano-systems capable of binding heparin as effectively as protamine

New nano-systems developed in York may eventually help patients recover from surgery without the danger of allergic reactions to drugs.

26 Apr 2011

MiMedx first quarter revenue increases to $1,044,000

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products and bioimplants processed from human amniotic membrane, announced today its results for the three months ended March 31, 2011.

26 Apr 2011

BIOBASE introduces new genome sequence custom annotation tool

BIOBASE announced its launch of a new custom annotation tool designed to aid in functional annotation of next generation sequences from uncharacterized genomes.

26 Apr 2011

Teleflex first quarter net revenue increases 6% to $388.7 million

Teleflex Incorporated, a leading, global provider of medical technology products, today reported financial results for the three months ended March 27, 2011.

26 Apr 2011

Some bacteria avoid antibiotic treatments by going 'off the grid' like rogue secret agents

Going "off the grid," like rogue secret agents, some bacteria avoid antibiotic treatments by essentially shutting down and hiding until it's safe to come out again, says Thomas Wood, professor in the Artie McFerrin Department of Chemical Engineering at Texas A&M University.

26 Apr 2011

Active Healthy Kids Canada releases 2011 Report Card on physical activity for children, youth

School's out, do you know what your kids are doing? You may want to think again if you believe they are being physically active.

26 Apr 2011

ATA calls on CMS to remove Medicare's outdated restrictions on telemedicine for ACOs

The American Telemedicine Association (ATA) has called on the Centers for Medicare and Medicaid Services (CMS) to use its authority to waive the restriction-riddled Medicare telemedicine statute for the new Accountable Care Organizations (ACOs).

26 Apr 2011

Pediatricians plan April 27 rally to protect children's health care access

On Wednesday, April 27, physician residents at Lucile Packard Children's Hospital plan to "Stand For Kids: Protect Children's Healthcare" in a rally to urge members of Congress to protect vulnerable children's access to health care as a congressional budget bill evolves.

26 Apr 2011

Anti-inflammatory drugs reduce effectiveness of widely used antidepressant medications

Scientists at the Fisher Center for Alzheimer's Disease Research at The Rockefeller University, led by Paul Greengard, Ph.D., and Jennifer Warner-Schmidt, Ph.D., have shown that anti-inflammatory drugs, which include ibuprofen, aspirin and naproxen, reduce the effectiveness of the most widely used class of antidepressant medications, the selective serotonin reuptake inhibitors, or SSRIs, taken for depression and obsessive-compulsive disorder and anxiety disorders.

26 Apr 2011

Experts to present research on vascular biology and disease at ATVB meetings

Nearly 1,200 experts in cardiovascular medicine, vascular biology, endocrinology, hematology and other disciplines are expected to attend the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology 2011 Scientific Sessions, April 28-30, in Chicago, Ill.

26 Apr 2011

Centene first quarter premium and service revenues increase 15.4% to $1.2 billion

Centene Corporation today announced its financial results for the quarter ended March 31, 2011.

26 Apr 2011

Collins, Orszag criticize Ryan plan; Santorum rues Medicare prescription benefit vote

As former Pennsylvania Sen. Rick Santorum contemplates a bid for the GOP presidential nomination, he expresses regret over his vote for the unfunded Medicare prescription drug bill. Sen. Collins says she'll oppose Ryan plan, while Peter Orszag says it would increase overall health care costs.

26 Apr 2011

Ohio State Roundtable to discuss about cancer drug development

The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Friends of Cancer Research are convening a high-level group of stakeholders to discuss current obstacles halting co-development of two or more experimental drugs for the treatment of cancer.

26 Apr 2011